iLine Microsystems

iLine Microsystems

Barcelona, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.2M

Overview

iLine Microsystems is a privately-held, commercial-stage diagnostics company specializing in point-of-care hemostasis monitoring. Its flagship microINR system, launched in 2011, utilizes a proprietary microfluidic Lab-on-a-Chip platform to provide rapid, reliable PT/INR testing for patients on anticoagulants. The company has achieved international expansion, manufacturing millions of test chips annually, and is developing new products like the microDOAC to address the growing market for decentralized coagulation testing and telemedicine. iLine's strategy is centered on providing connected, high-throughput solutions to alleviate pressure on saturated healthcare systems and improve patient quality of life.

HemostasisCardiovascular

Technology Platform

Proprietary microfluidic and Lab-on-a-Chip (LOC) platform integrating sample handling, reagents, mixing, detection, and QC on a disposable plastic chip. Combined with a Machine Vision System (MVS) in meters for optical clot detection and data processing. Enables miniaturized, one-step, connected POCT coagulation assays.

Funding History

1
Total raised:$1.2M
Seed$1.2M

Opportunities

The shift towards decentralized healthcare and patient self-testing creates strong demand for easy-to-use, connected POCT devices.
The growing use of DOACs presents a new market for quantitative monitoring tests in emergency and special clinical situations.
Integration with telemedicine platforms allows for remote patient management, aligning with global healthcare trends.

Risk Factors

Faces intense competition from large, established diagnostics corporations in the coagulation testing space.
Regulatory approval and securing reimbursement for new products like microDOAC are significant hurdles.
The long-term market for core INR testing could be impacted by the increasing adoption of DOACs, which require less routine monitoring.

Competitive Landscape

iLine competes in the POCT coagulation monitoring market against major players like Roche (CoaguChek), Abbott, and Siemens Healthineers, which have broad portfolios and global sales reach. It differentiates through its proprietary microfluidic Lab-on-a-Chip technology, focus on connectivity for telemedicine, and a specific product range targeting both professional and self-testing settings for anticoagulation management.